 Alan Schocket
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urticaria | 14 | 2006 | 50 | 1.010 |
Why?
| | Patch Tests | 1 | 2021 | 50 | 0.770 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 47 | 0.750 |
Why?
| | Metals | 1 | 2021 | 111 | 0.730 |
Why?
| | Prosthesis Failure | 1 | 2021 | 120 | 0.730 |
Why?
| | Hypersensitivity | 2 | 2021 | 270 | 0.610 |
Why?
| | Thyroid Diseases | 1 | 2004 | 30 | 0.240 |
Why?
| | Antilymphocyte Serum | 5 | 1988 | 66 | 0.210 |
Why?
| | Anaphylaxis | 5 | 1995 | 146 | 0.190 |
Why?
| | Histamine H1 Antagonists | 5 | 1982 | 33 | 0.170 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1787 | 0.140 |
Why?
| | Thyroiditis, Autoimmune | 1 | 1995 | 15 | 0.140 |
Why?
| | Histamine H2 Antagonists | 3 | 1981 | 31 | 0.140 |
Why?
| | Chronic Disease | 8 | 2006 | 1630 | 0.130 |
Why?
| | Vasculitis | 4 | 1984 | 74 | 0.120 |
Why?
| | Multiple Sclerosis | 4 | 1980 | 384 | 0.120 |
Why?
| | Histamine | 7 | 1984 | 65 | 0.110 |
Why?
| | Hypersensitivity, Delayed | 4 | 1988 | 52 | 0.110 |
Why?
| | Skin Tests | 6 | 1986 | 135 | 0.100 |
Why?
| | Middle Aged | 16 | 2021 | 27510 | 0.090 |
Why?
| | Food Hypersensitivity | 2 | 1986 | 260 | 0.080 |
Why?
| | Lymphotoxin-alpha | 2 | 1978 | 10 | 0.080 |
Why?
| | Humans | 37 | 2021 | 118251 | 0.070 |
Why?
| | Male | 23 | 2021 | 57474 | 0.070 |
Why?
| | Histamine Release | 1 | 2006 | 22 | 0.070 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 1979 | 228 | 0.070 |
Why?
| | Thyroxine | 2 | 1996 | 62 | 0.070 |
Why?
| | Female | 21 | 2021 | 61261 | 0.070 |
Why?
| | Immunoglobulin E | 2 | 2006 | 366 | 0.060 |
Why?
| | Complement Activating Enzymes | 1 | 1984 | 4 | 0.060 |
Why?
| | p-Methoxy-N-methylphenethylamine | 5 | 1988 | 9 | 0.060 |
Why?
| | Pressure | 4 | 1988 | 226 | 0.060 |
Why?
| | Angioedema | 1 | 2004 | 17 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2021 | 12929 | 0.060 |
Why?
| | Hydroxychloroquine | 1 | 1984 | 59 | 0.060 |
Why?
| | Polyarteritis Nodosa | 2 | 1980 | 7 | 0.060 |
Why?
| | Bronchial Provocation Tests | 2 | 1981 | 54 | 0.060 |
Why?
| | Immunoglobulin M | 4 | 1979 | 251 | 0.060 |
Why?
| | Adult | 23 | 1998 | 31324 | 0.060 |
Why?
| | Skin | 3 | 1984 | 657 | 0.050 |
Why?
| | Mycosis Fungoides | 1 | 1982 | 62 | 0.050 |
Why?
| | Asthma | 3 | 1998 | 2143 | 0.050 |
Why?
| | Bronchial Spasm | 2 | 1981 | 7 | 0.050 |
Why?
| | Immune Complex Diseases | 2 | 1980 | 9 | 0.050 |
Why?
| | Complement C1 | 2 | 1980 | 2 | 0.050 |
Why?
| | Autoantibodies | 4 | 1996 | 1334 | 0.050 |
Why?
| | Piperazines | 1 | 1983 | 316 | 0.050 |
Why?
| | Cimetidine | 4 | 1981 | 16 | 0.050 |
Why?
| | Antigen-Antibody Complex | 4 | 1988 | 90 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2004 | 398 | 0.050 |
Why?
| | Anemia, Hypochromic | 1 | 1980 | 3 | 0.050 |
Why?
| | Erythropoiesis | 1 | 1980 | 33 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 1980 | 130 | 0.050 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1979 | 14 | 0.050 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1979 | 7 | 0.050 |
Why?
| | Mixed Connective Tissue Disease | 1 | 1979 | 8 | 0.040 |
Why?
| | Shellfish | 1 | 1979 | 7 | 0.040 |
Why?
| | Physical Exertion | 2 | 1981 | 221 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 2 | 1998 | 466 | 0.040 |
Why?
| | Diet | 1 | 1986 | 1143 | 0.040 |
Why?
| | Complement System Proteins | 3 | 1980 | 290 | 0.040 |
Why?
| | Iron | 1 | 1980 | 247 | 0.040 |
Why?
| | Ascites | 1 | 1978 | 37 | 0.040 |
Why?
| | Pleural Effusion | 1 | 1978 | 47 | 0.040 |
Why?
| | Chlorpheniramine | 3 | 1981 | 10 | 0.040 |
Why?
| | Bronchodilator Agents | 1 | 1998 | 251 | 0.040 |
Why?
| | Cytotoxicity Tests, Immunologic | 4 | 1979 | 49 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 1982 | 762 | 0.030 |
Why?
| | Antibodies | 1 | 1977 | 381 | 0.030 |
Why?
| | Hydroxyzine | 3 | 1981 | 6 | 0.030 |
Why?
| | Eating | 1 | 1995 | 366 | 0.030 |
Why?
| | Immunoglobulin G | 4 | 1982 | 785 | 0.030 |
Why?
| | Antibodies, Antinuclear | 2 | 1982 | 56 | 0.030 |
Why?
| | Aged | 9 | 1998 | 19594 | 0.030 |
Why?
| | Diagnosis, Differential | 2 | 1995 | 1379 | 0.020 |
Why?
| | Self Administration | 1 | 1990 | 125 | 0.020 |
Why?
| | Administration, Oral | 2 | 1983 | 753 | 0.020 |
Why?
| | Epinephrine | 1 | 1990 | 166 | 0.020 |
Why?
| | Purpura, Hyperglobulinemic | 1 | 1988 | 2 | 0.020 |
Why?
| | Drug Hypersensitivity | 2 | 1988 | 85 | 0.020 |
Why?
| | Time Factors | 4 | 1995 | 6368 | 0.020 |
Why?
| | Acute Disease | 1 | 1990 | 933 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 1990 | 1163 | 0.020 |
Why?
| | Clinical Trials as Topic | 2 | 1981 | 964 | 0.020 |
Why?
| | Radioallergosorbent Test | 1 | 1986 | 4 | 0.020 |
Why?
| | Injections, Intravenous | 3 | 1983 | 209 | 0.020 |
Why?
| | Blood Sedimentation | 2 | 1982 | 34 | 0.020 |
Why?
| | Exercise | 1 | 1995 | 1647 | 0.020 |
Why?
| | Intradermal Tests | 1 | 1984 | 2 | 0.020 |
Why?
| | Hemolytic Plaque Technique | 1 | 1984 | 30 | 0.020 |
Why?
| | Biopsy | 2 | 1988 | 1078 | 0.020 |
Why?
| | Complement C1q | 1 | 1984 | 38 | 0.020 |
Why?
| | Benzothiazoles | 1 | 1983 | 37 | 0.010 |
Why?
| | Syndrome | 1 | 1984 | 343 | 0.010 |
Why?
| | Lymphocytes | 2 | 1988 | 346 | 0.010 |
Why?
| | Leukocytosis | 1 | 1982 | 34 | 0.010 |
Why?
| | Caseins | 1 | 1982 | 22 | 0.010 |
Why?
| | Mast Cells | 1 | 1983 | 115 | 0.010 |
Why?
| | Adolescent | 7 | 1998 | 18364 | 0.010 |
Why?
| | Oxamic Acid | 1 | 1982 | 2 | 0.010 |
Why?
| | Hemophilia A | 1 | 1983 | 69 | 0.010 |
Why?
| | Cyproheptadine | 1 | 1981 | 7 | 0.010 |
Why?
| | Terbutaline | 1 | 1981 | 9 | 0.010 |
Why?
| | Cholinergic Fibers | 1 | 1981 | 19 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1982 | 181 | 0.010 |
Why?
| | Prednisone | 1 | 1982 | 235 | 0.010 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1983 | 219 | 0.010 |
Why?
| | Methylprednisolone Hemisuccinate | 1 | 1981 | 3 | 0.010 |
Why?
| | Antibody Formation | 1 | 1982 | 275 | 0.010 |
Why?
| | Methylprednisolone | 1 | 1981 | 84 | 0.010 |
Why?
| | Pleural Diseases | 1 | 1980 | 21 | 0.010 |
Why?
| | Complement C3 | 2 | 1980 | 191 | 0.010 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 1980 | 81 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1980 | 116 | 0.010 |
Why?
| | Dextrans | 1 | 1980 | 74 | 0.010 |
Why?
| | Airway Resistance | 1 | 1979 | 33 | 0.010 |
Why?
| | Placebos | 1 | 1979 | 202 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1979 | 152 | 0.010 |
Why?
| | Vital Capacity | 1 | 1979 | 260 | 0.010 |
Why?
| | Gastrointestinal Diseases | 1 | 1980 | 186 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1981 | 964 | 0.010 |
Why?
| | Water | 1 | 1981 | 422 | 0.010 |
Why?
| | Consanguinity | 1 | 1978 | 49 | 0.010 |
Why?
| | Forced Expiratory Volume | 1 | 1979 | 520 | 0.010 |
Why?
| | Hemoglobins | 1 | 1980 | 318 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 1978 | 56 | 0.010 |
Why?
| | Subacute Sclerosing Panencephalitis | 1 | 1977 | 6 | 0.010 |
Why?
| | Steroids | 1 | 1998 | 153 | 0.010 |
Why?
| | Cold Temperature | 1 | 1978 | 130 | 0.010 |
Why?
| | Binding Sites | 1 | 1980 | 1221 | 0.010 |
Why?
| | Risk | 1 | 1980 | 849 | 0.010 |
Why?
| | Measles virus | 1 | 1977 | 11 | 0.010 |
Why?
| | Vaccinia virus | 1 | 1977 | 30 | 0.010 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1977 | 62 | 0.010 |
Why?
| | Guidelines as Topic | 1 | 1998 | 261 | 0.010 |
Why?
| | Statistics as Topic | 1 | 1977 | 307 | 0.010 |
Why?
| | Virus Diseases | 1 | 1978 | 197 | 0.010 |
Why?
| | Double-Blind Method | 1 | 1979 | 1683 | 0.010 |
Why?
| | Treatment Failure | 1 | 1996 | 340 | 0.010 |
Why?
| | Cell Line | 1 | 1980 | 2693 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 1978 | 1062 | 0.010 |
Why?
| | Lung Diseases | 1 | 1980 | 709 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 1977 | 538 | 0.010 |
Why?
| | Child | 5 | 1996 | 19033 | 0.010 |
Why?
| | Logistic Models | 1 | 1998 | 1896 | 0.010 |
Why?
| | Temperature | 2 | 1988 | 621 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 1996 | 517 | 0.010 |
Why?
| | DNA | 1 | 1978 | 1385 | 0.010 |
Why?
| | Ultracentrifugation | 1 | 1988 | 49 | 0.010 |
Why?
| | Pregnancy | 1 | 1980 | 5671 | 0.000 |
Why?
| | Leukocyte Count | 1 | 1988 | 303 | 0.000 |
Why?
| | Aging | 1 | 1978 | 1675 | 0.000 |
Why?
| | Cross-Sectional Studies | 1 | 1998 | 4521 | 0.000 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1983 | 25 | 0.000 |
Why?
| | Factor VIII | 1 | 1983 | 55 | 0.000 |
Why?
| | Candidiasis | 1 | 1983 | 59 | 0.000 |
Why?
| | Pruritus | 1 | 1981 | 60 | 0.000 |
Why?
| | Abdomen, Acute | 1 | 1980 | 19 | 0.000 |
Why?
| | Cytomegalovirus Infections | 1 | 1983 | 187 | 0.000 |
Why?
| | Cryoglobulins | 1 | 1980 | 7 | 0.000 |
Why?
| | Fixatives | 1 | 1980 | 16 | 0.000 |
Why?
| | Serum Albumin, Bovine | 1 | 1980 | 67 | 0.000 |
Why?
| | Abdomen | 1 | 1980 | 110 | 0.000 |
Why?
| | Hot Temperature | 1 | 1981 | 333 | 0.000 |
Why?
| | Fluorescent Antibody Technique | 1 | 1980 | 409 | 0.000 |
Why?
| | Rabbits | 1 | 1980 | 779 | 0.000 |
Why?
| | Microscopy, Fluorescence | 1 | 1980 | 410 | 0.000 |
Why?
| | Rosette Formation | 1 | 1978 | 16 | 0.000 |
Why?
| | Concanavalin A | 1 | 1978 | 74 | 0.000 |
Why?
| | Blood Cell Count | 1 | 1978 | 52 | 0.000 |
Why?
| | Lectins | 1 | 1978 | 49 | 0.000 |
Why?
| | Heart Rate | 1 | 1981 | 729 | 0.000 |
Why?
| | Immunization | 1 | 1980 | 412 | 0.000 |
Why?
| | Radiography | 1 | 1980 | 860 | 0.000 |
Why?
| | Immunoglobulin A | 1 | 1978 | 174 | 0.000 |
Why?
| | Anxiety | 1 | 1981 | 845 | 0.000 |
Why?
| | Pain | 1 | 1980 | 736 | 0.000 |
Why?
| | B-Lymphocytes | 1 | 1978 | 767 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1980 | 4574 | 0.000 |
Why?
| | T-Lymphocytes | 1 | 1978 | 1770 | 0.000 |
Why?
| | Child, Preschool | 1 | 1980 | 9448 | 0.000 |
Why?
| | Animals | 1 | 1980 | 33152 | 0.000 |
Why?
|
|
Schocket's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|